Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 6/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | F10 | P00742 | 1/20 | 0.52 |
| ▸ | ABAT | P80404 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.42 |
| ▸ | F11 | P03951 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69668 | 0.86 | LOXL2 (0.59) | LOXL2TAAR1F10ABATHDAC3 | |
| SCHEMBL22361625 | 0.86 | LOXL2 (0.59) | LOXL2TAAR1F10ABATHDAC3 | |
| SCHEMBL69667 | 0.86 | LOXL2 (0.59) | LOXL2TAAR1F10ABATHDAC3 | |
| SCHEMBL203283 | 0.82 | ALDH1A1 (0.61) | LOXL2TAAR1HDAC3HDAC6NCOR2 | |
| SCHEMBL13885490 | 0.82 | CES2 (0.65) | LOXL2TAAR1F10HDAC3HDAC6 | |
| Hydrochloric Acid SCHEMBL2450035 | 0.80 | ALDH1A1 (0.58) | LOXL2TAAR1HDAC3HDAC6NCOR2 | |
| Benzene SCHEMBL734439 | 0.79 | LOXL2 (0.80) | LOXL2TAAR1F10ABATHRH3 | |
| SCHEMBL3173519 | 0.78 | CALM1 (0.60) | CYP2C9TSHRCES2CES1PLA2G10 | |
| SCHEMBL21241003 | 0.77 | ALDH1A1 (0.48) | LOXL2TAAR1F10ABAT | |
| SCHEMBL80681 | 0.77 | LMNA (0.49) | LOXL2TAAR1F10CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130172529-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES S.A. (ES) | 2013-07-04 | — | — | US | disclosed |
| EP-2019118-B1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES SA (ES) | 2012-11-07 | — | — | EP | disclosed |
| US-20110166071-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES S.A. (ES) | 2011-07-07 | — | — | US | disclosed |
| EP-2019118-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN Peptides, S.A. (ES) | 2009-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166071-A1 | METHOD FOR SYNTHESIZING THYMOSINS | PTMS, PTMA, VIP | LOXL2 4275/4885TAAR1 2838/4885F10 986/4885 |
| US-20130172529-A1 | METHOD FOR SYNTHESIZING THYMOSINS | PTMS, PTMA, VIP | LOXL2 4275/4885TAAR1 2838/4885F10 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.